EXETER, N.H. (AP) - Bentley Pharmaceuticals Inc. said Thursday shareholders
will receive a slightly lower price from purchaser Teva Pharmaceutical
Industries Ltd. now that Bentley has spun off its drug delivery business, CPEX
Pharmaceuticals.
Israel-based Teva agreed to buy Bentley for about $15.02 per share cash, or
about $360 million, in March to boost its generic drug operations in Spain.
It is now offering about $14.82 per share cash for Bentley.
Shareholders are scheduled to vote on the agreement at a special meeting on
July 22.
Copyright 2008 Associated Press. All rights reserved. This material may not
be published, broadcast, rewritten, or redistributed
tf.TFN-Europe_newsdesk@thomson.com
lam
COPYRIGHT
Copyright Thomson Financial News Limited 2007. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content,
including by framing or similar means, is expressly prohibited without the prior
written consent of Thomson Financial News.
|